J Liu1,2, X Liu3, B Wei4, J Liu1,2, Y Wang1,2, H Liu1,2. 1. Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, Chengdu 610041, China. 2. Key Laboratory of Birth Defects and Related Gynecological Diseases of the Ministry of Education, Sichuan University, Chengdu 610041, China. 3. Department of Gynecology, The Sixth People's Hospital of Chengdu, Chengdu 610051. 4. Department of Gynecology, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Abstract
OBJECTIVE: To construct an ovarian cancer cell line stably overexpressing XAF1 gene and observe the effects of XAF1 gene overexpression on proliferation, apoptosis, cell cycle and sensitivity to paclitaxel of the cells. OBJECTIVE: Ovarian cancer A2780 cells were transfected with the plasmids pcDNA3.1(+) or pcDNA3.1(+)-XAF1, and the cells stably Over expressing XAF1 (A2780/XAF1 cells) were screened using G418. Cell clone formation assay and CCK8 assay were used to evaluate the changes in proliferation and paclitaxel sensitivity of the transfected cells, and cell cycle and apoptosis of the cells were analyzed using flow cytometry. OBJECTIVE: We successfully obtained A2780/XAF1 cells stably overexpressing XAF1, which exhibited no significant changes in cell morphology. Compared with the negative control cells (A2780/NC), A2780/XAF1 cells had lowered clone formation ability (P=0.0016) and attenuated proliferative activity on the first (P=0.009) and third (P=0.0035) days after cell adherence with also a significantly increased percentage of cells in G2-M phase (P < 0.001). A2780/XAF1 cells showed significantly higher apoptosis rates than A2780/NC cells in the absence of apoptotic stimulation, in serum-free culture or following paclitaxel induction (P < 0.001). The proliferative activity of A2780/XAF1 cells was significantly lower than that of A2780/NC cells after exposure to different paclitaxel concentrations (P < 0.001). The half inhibitory concentration of paclitaxel was significantly lower in A2780/XAF1 than in A2780/NC cells. OBJECTIVE: Overexpression of XAF1 significantly inhibits the proliferation, induces cell cycle arrest, promotes apoptosis, and increases paclitaxel sensitivity in ovarian cancer cells.
OBJECTIVE: To construct an ovarian cancer cell line stably overexpressing XAF1 gene and observe the effects of XAF1 gene overexpression on proliferation, apoptosis, cell cycle and sensitivity to paclitaxel of the cells. OBJECTIVE: Ovarian cancer A2780 cells were transfected with the plasmids pcDNA3.1(+) or pcDNA3.1(+)-XAF1, and the cells stably Over expressing XAF1 (A2780/XAF1 cells) were screened using G418. Cell clone formation assay and CCK8 assay were used to evaluate the changes in proliferation and paclitaxel sensitivity of the transfected cells, and cell cycle and apoptosis of the cells were analyzed using flow cytometry. OBJECTIVE: We successfully obtained A2780/XAF1 cells stably overexpressing XAF1, which exhibited no significant changes in cell morphology. Compared with the negative control cells (A2780/NC), A2780/XAF1 cells had lowered clone formation ability (P=0.0016) and attenuated proliferative activity on the first (P=0.009) and third (P=0.0035) days after cell adherence with also a significantly increased percentage of cells in G2-M phase (P < 0.001). A2780/XAF1 cells showed significantly higher apoptosis rates than A2780/NC cells in the absence of apoptotic stimulation, in serum-free culture or following paclitaxel induction (P < 0.001). The proliferative activity of A2780/XAF1 cells was significantly lower than that of A2780/NC cells after exposure to different paclitaxel concentrations (P < 0.001). The half inhibitory concentration of paclitaxel was significantly lower in A2780/XAF1 than in A2780/NC cells. OBJECTIVE: Overexpression of XAF1 significantly inhibits the proliferation, induces cell cycle arrest, promotes apoptosis, and increases paclitaxel sensitivity in ovarian cancer cells.
Authors: Jae Young Jang; Hyo Jong Kim; Sung-Gil Chi; Kil Yeon Lee; Ki Deuk Nam; Nam Hoon Kim; Sang Kil Lee; Kwang Ro Joo; Seok Ho Dong; Byung-Ho Kim; Young Woon Chang; Joung Il Lee; Rin Chang Journal: Korean J Gastroenterol Date: 2005-04
Authors: Shui Ping Tu; Peter Liston; Jian Tao Cui; Marie C M Lin; Xiao Hua Jiang; Yi Yang; Qing Gu; Shi Hu Jiang; Ching Tung Lum; Hsiang Fu Kung; Robert G Korneluk; Benjamin Chun-Yu Wong Journal: Int J Cancer Date: 2009-08-01 Impact factor: 7.396
Authors: O Cristina Micali; Herman H Cheung; Stéphanie Plenchette; Sandra L Hurley; Peter Liston; Eric C LaCasse; Robert G Korneluk Journal: BMC Cancer Date: 2007-03-21 Impact factor: 4.430
Authors: Li Ming Zhu; Dong Mei Shi; Qiang Dai; Xiao Jiao Cheng; Wei Yan Yao; Ping Hu Sun; Yanfei Ding; Min Min Qiao; Yun Lin Wu; Shi Hu Jiang; Shui Ping Tu Journal: Oncotarget Date: 2014-07-30
Authors: Rama Rathore; Jennifer E McCallum; Elizabeth Varghese; Ana-Maria Florea; Dietrich Büsselberg Journal: Apoptosis Date: 2017-07 Impact factor: 4.677